Fully MHC-Disparate Mixed Hemopoietic Chimeras Show Specific Defects in the Control of Chronic Viral Infections1

The establishment of mixed allogeneic chimerism can induce donor-specific transplantation tolerance across full MHC barriers. However, a theoretical disadvantage of this approach is the possibility that the state of mixed chimerism might negatively affect the recipient’s immune competence to control pathogens. Previous studies using murine models have not supported this hypothesis, because they indicate that acute viral infections are cleared by chimeric animals with similar kinetics to that of unmanipulated controls. However, chronic or persistent viral infections often require a more complex and sustained response with cooperation between CD4 Th cells, CTL, and B cells for effective control. The current study indicates that profound defects become manifest in the control of chronic pathogenic infections in MHC-disparate mixed allogeneic chimeric mice. Furthermore, we show that ineffective priming of the donor-restricted CTL response leads to virus persistence, as well as severe T cell exhaustion. Our results further suggest that either T cell adoptive immunotherapy or selected MHC haplotype matching partially restore immune competence. These approaches may facilitate the translation of mixed chimerism therapeutic regimens.

[1]  P. Doherty,et al.  Structural determinants of T-cell receptor bias in immunity , 2006, Nature Reviews Immunology.

[2]  R. Colvin,et al.  Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  Arjun Srinivasan,et al.  Transmission of lymphocytic choriomeningitis virus by organ transplantation. , 2006, The New England journal of medicine.

[4]  R. Ahmed,et al.  Patients, Pathogens, and Protective Immunity: The Relevance of Virus-Induced Alloreactivity in Transplantation , 2006, The Journal of Immunology.

[5]  G. Freeman,et al.  Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.

[6]  C. Larsen,et al.  NK Cells Mediate Costimulation Blockade‐Resistant Rejection of Allogeneic Stem Cells During Nonmyeloablative Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  D. Sachs,et al.  Long-Term Acceptance of Fully Allogeneic Cardiac Grafts by Cotransplantation of Vascularized Thymus in Miniature Swine , 2006, Transplantation.

[8]  P. Klenerman,et al.  T cells and viral persistence: lessons from diverse infections , 2005, Nature Immunology.

[9]  L. Teyton,et al.  Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection , 2005, Journal of Virology.

[10]  D. Sachs,et al.  Heart and en-bloc thymus transplantation in miniature swine. , 2005, The Journal of thoracic and cardiovascular surgery.

[11]  T. Starzl Chimerism and tolerance in transplantation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Randhawa,et al.  HLA Mismatching Increases the Risk of BK Virus Nephropathy in Renal Transplant Recipients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  S. Messinger,et al.  Cytomegalovirus Prevalence and Transmission After Islet Allograft Transplant in Patients with Type 1 Diabetes Mellitus , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  S. Strober,et al.  Approaches to transplantation tolerance in humans. , 2004, Transplantation.

[15]  A. Agadir,et al.  Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. , 2004, Clinical immunology.

[16]  Alessandro Sette,et al.  Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. , 2003, Virology.

[17]  E. Wherry,et al.  Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells1 , 2003, The Journal of Immunology.

[18]  E. Wherry,et al.  Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment , 2003, Journal of Virology.

[19]  N. Babel,et al.  Adoptiver Transfer EBV-spezifischer T-Lymphozyten bei chronisch aktiver EBV-Infektion , 2003 .

[20]  R. Zinkernagel,et al.  Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  James F. Jones,et al.  Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. , 2002, Blood.

[22]  T. Klimkait,et al.  Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. , 2002, The New England journal of medicine.

[23]  C. Larsen,et al.  A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation. , 2002, Blood.

[24]  F. Graziano,et al.  Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. , 2001, Journal of immunological methods.

[25]  C. Larsen,et al.  Costimulation Blockade, Busulfan, and Bone Marrow Promote Titratable Macrochimerism, Induce Transplantation Tolerance, and Correct Genetic Hemoglobinopathies with Minimal Myelosuppression1 , 2001, The Journal of Immunology.

[26]  M. Sykes,et al.  Mixed chimerism and transplant tolerance. , 2001, Immunity.

[27]  P. Doherty,et al.  Quantitative analysis of the CD8+ T-cell response to readily eliminated and persistent viruses. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[28]  C. Larsen,et al.  Cutting Edge: Administration of Anti-CD40 Ligand and Donor Bone Marrow Leads to Hemopoietic Chimerism and Donor-Specific Tolerance Without Cytoreductive Conditioning1 , 2000, The Journal of Immunology.

[29]  M. Sykes,et al.  Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment , 2000, Nature Medicine.

[30]  C. Benoist,et al.  Mice lacking all conventional MHC class II genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F. Lemonnier,et al.  Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and antilymphocytic choriomeningitis virus cytolytic responses , 1999, European journal of immunology.

[32]  Spyros A. Kalams,et al.  The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses , 1998, The Journal of experimental medicine.

[33]  J. Altman,et al.  Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.

[34]  M. Sykes,et al.  Extrathymic T Cell Deletion and Allogeneic Stem Cell Engraftment Induced with Costimulatory Blockade Is Followed by Central T Cell Tolerance , 1998, The Journal of experimental medicine.

[35]  P. Doherty,et al.  Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: functional restriction to host MHC. , 1998, Journal of immunology.

[36]  R M Zinkernagel,et al.  A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Sidney,et al.  Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. , 1996, Journal of immunology.

[38]  E. Woodle,et al.  Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. , 1996, Transplantation.

[39]  P. Linsley,et al.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways , 1996, Nature.

[40]  R. Zinkernagel,et al.  The roles of perforin‐ and Fas‐dependent cytotoxicity in protection against cytopathic and noncytopathic viruses , 1995, European journal of immunology.

[41]  R. Ahmed,et al.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.

[42]  M. Sykes,et al.  Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. , 1994, Journal of immunology.

[43]  R. Ahmed,et al.  Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus , 1993, Journal of virology.

[44]  P. Matzinger Why Positive Selection? , 1993, Immunological reviews.

[45]  C. Davis The prevention of cytomegalovirus disease in renal transplantation. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  R. Zinkernagel,et al.  Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2----P1) irradiation chimeras. , 1989, Cellular immunology.

[47]  D. Sachs,et al.  Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen , 1989, The Journal of experimental medicine.

[48]  R. Fernandez-Botran,et al.  Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells , 1988, Nature.

[49]  A. Singer,et al.  Experimentation and thymic selection. , 1988, Journal of immunology.

[50]  H. Waldmann,et al.  Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance , 1986, Nature.

[51]  S. Slavin,et al.  Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation. , 1985, Transplantation.

[52]  J. Bluestone,et al.  Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance , 1985, The Journal of experimental medicine.

[53]  R. Ahmed,et al.  Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence , 1984, The Journal of experimental medicine.

[54]  A. Singer,et al.  Self recognition in allogeneic radiation bone marrow chimeras. A radiation- resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells , 1981, The Journal of experimental medicine.

[55]  R. Zinkernagel,et al.  On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. , 1980, Journal of immunology.

[56]  R. Zinkernagel,et al.  Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or - incompatible thymus grafts , 1980, The Journal of experimental medicine.

[57]  P. Fink,et al.  The Influence of Thymus H‐2 Antigens on the Specificity of Maturing Killer and Helper Cells , 1978, Immunological reviews.

[58]  P. Reinke,et al.  [Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection]. , 2003, Deutsche medizinische Wochenschrift.

[59]  D. Sachs,et al.  Mixed chimerism. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[60]  J. Altman,et al.  In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. , 1998, Advances in experimental medicine and biology.